Company / Financials
Lilly (Eli) Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$65.2B
FY2025 · +44.7% YoY
Net Income
$20.6B
FY2025 · +94.9% YoY
Profit Margin
31.7%
FY2025 · net income / revenue
ROE
77.8%
FY2025 · return on equity
Total Assets
$112.5B
FY2025
Total Debt
$40.9B
1.54x debt/equity
Equity
$26.5B
FY2025
ROA
18.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$65.2B+44.7% YoYNet Income HistoryProfit after all expenses and taxes$20.6B+94.9% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$11.1B+31.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$11.1B+29.1% YoYR&D Expense HistoryResearch and development spending$13.3B+21.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$339.8MIncome Tax HistoryTotal income tax expense$5.1B+143.6% YoYEPS (Basic) HistoryBasic earnings per share$5.82-16.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$5.80-15.9% YoYShares Outstanding HistoryWeighted average diluted shares outstanding903.3M-0.1% YoY